Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-063932

Director sold 2,000 shares at an average $55.93 ($111,856)

  • Director acquired 2,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
HERSHBERG ROBERT Director 2020-12-15 Option exercise +2,000 $0.45 $900 2,000 D
HERSHBERG ROBERT Director 2020-12-15 Sale −1,759 $55.78 $98,117 241 D
HERSHBERG ROBERT Director 2020-12-15 Sale −241 $57.01 $13,739 0 D
Derivatives
HERSHBERG ROBERT Director 2020-12-15 Option exercise · Stock Option (Right to Buy) −2,000 59,000 D
Open-market sales · 2,000 sh · avg $55.93 · $111,856
Loading xslF345X03/doc4.xml…